Otsuka Pharmaceutical, Inc., Philippines clinical trials
A country office of Otsuka Holdings Co., Ltd.
The registry lists 6 studies whose lead sponsor is Otsuka Pharmaceutical, Inc., Philippines. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 1, 2020.
Registry sponsor names on this page
- Otsuka Pharmaceutical, Inc., Philippines6 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Otsuka Holdings Co., Ltd. studies →
- "Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"Status unknownNCT04641780
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines
- Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing SurveillanceCompletedNCT02730390
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines
- Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced GastropathyCompletedNCT00641004Phase 4
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines
- Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency RoomCompletedNCT01091337Phase 4
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines
- Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the PhilippinesCompletedNCT01076478Phase 4
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines
- Tiotropium + Procaterol vs Tiotropium + Placebo in COPD PatientsTerminatedNCT00394485Phase 4
Sponsor listed in the registry: Otsuka Pharmaceutical, Inc., Philippines